Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-01-08 10:35 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-280,000 vol |
70,000 | |
Filed 2021-01-08 10:34 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-8,000 vol |
2,000 | |
Filed 2020-09-02 14:56 Tx date 2020-09-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$170,000
+100,000 vol $1.70 each |
350,000 | |
Filed 2020-07-31 19:27 Tx date 2020-07-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,230
+3,000 vol $1.41 each |
10,000 | |
Filed 2019-11-15 14:40 Tx date 2019-11-14 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,926
+7,000 vol $0.418 each |
7,000 | |
Filed 2019-11-15 14:36 Tx date 2019-10-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-15 14:00 Tx date 2019-10-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
250,000 |